CSIMarket
 
Teleflex Incorporated  (NYSE: TFX)
 
Price: $138.3600 $-1.60 -1.143%
Day's High: $140.58999633789062 Week Perf: -2.6 %
Day's Low: $ 137.35 30 Day Perf: -0.38 %
Volume (M): 463,907 52 Wk High: $ 145.00
Volume (M$): $ 0 52 Wk Avg: $123.19
Open: $138.70 52 Wk Low: $100.18



 Market Capitalization (Millions $) 6,123
 Shares Outstanding (Millions) 44
 Employees 15,500
 Revenues (TTM) (Millions $) 1,838
 Net Income (TTM) (Millions $) -1,009
 Cash Flow (TTM) (Millions $) 52
 Capital Exp. (TTM) (Millions $) 84

Business Description


Teleflex Incorporated is a global manufacturer of medical devices known for delivering innovative solutions to healthcare professionals and patients around the world. The company operates primarily in two segments: medical and aerospace.

Medical Segment
The Medical Segment boasts a comprehensive range of products, which include vascular access devices, respiratory care equipment, surgical instruments, anesthesia supplies, and cardiology products. Among its notable offerings is the Arrow brand of catheters, designed to provide safe and efficient access to blood vessels for procedures such as hemodialysis and other critical applications. Teleflex is recognized for its commitment to innovation, having introduced a variety of advanced products, including the LMA Gastro Airway for endoscopic procedures and the Arrow ErgoPack System, which enhances ultrasound-guided central venous catheterization.

Aerospace Segment
In the Aerospace Segment, Teleflex is recognized as one of the leading producers of aerospace control systems and components, servicing both commercial and military aviation. Their product lineup includes essential components such as flight controls, thrust reversers, and landing gear systems for aircraft models including the Boeing 787 and Airbus A320.

Global Operations
Headquartered in Wayne, Pennsylvania, Teleflex employs over 13,000 individuals across more than 40 countries. The company markets its products in more than 130 countries, demonstrating a robust global presence within the medical and aerospace industries.

Commitment to Innovation and Quality
Teleflexs reputation for innovation is underscored by several awards, including accolades for its fluid management systems and breakthroughs in airway management technology. The companys dedication to quality ensures that it consistently delivers safe and effective medical devices that meet the rigorous demands of healthcare environments.

Corporate Responsibility
In addition to its focus on innovation and quality, Teleflex takes its corporate social responsibility seriously. The company has been proactive in supporting community initiatives, including significant contributions to COVID-19 relief efforts, highlighting its commitment to giving back to the communities it serves.

In summary, Teleflex Incorporated stands as a leading global medical device manufacturer dedicated to enhancing patient care and supporting healthcare professionals through advanced technologies and a strong commitment to corporate responsibility.


   Company Address: 550 E. Swedesford Rd., Suite 400 Wayne 19087 PA
   Company Phone Number: 225-6800   Stock Exchange / Ticker: NYSE TFX


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
BAX   -1.15%    
BDX   -2.52%    
BSX        2.05% 
ISRG   -1.58%    
MDT        3.22% 
SYK   -8.33%    
• View Complete Report
   



Clinical Study

Innovative Surgical Trials Propel Teleflex to the Forefront in Cardiovascular and Urological Care

Published Thu, Sep 11 2025 11:42 AM UTC

Teleflex Incorporated, a leading global provider of medical technologies, continues to set remarkable standards in both cardiovascular and urological care with a series of pivotal trials and new clinical findings. This article will explore the promising endeavor of the DUBSTENT DIABETES trial and new data insights related to their urological and bariatric surgery innovation...

Announcement

Teleflex Soars in Q1 as CEO Outlines Ambitious Vision for 2025 Growth,

Published Thu, May 1 2025 11:21 AM UTC

Teleflex Reports Strong First Quarter, Eyes Growth for 2025 Amidst Thriving Medical Device IndustryBy WAYNE, Pa. May 1, 2025 In a landscape marked by rapid technological advancements and increased demand for innovative medical devices, Teleflex Incorporated (NYSE: TFX) has released its financial results for the first quarter of 2025, highlighting a promising trajectory...

Product Service News

Teleflex Breaks New Ground with FDA Clearance for Life-Saving Devices and Antimicrobial Initiatives,

Published Wed, Apr 30 2025 11:06 AM UTC

Breaking New Ground: Teleflex Enhances Hemostatic Device Indications and Expands Portfolio Wayne, Pa. April 30, 2025 In a significant step forward for medical technology and patient care, Teleflex Incorporated (NYSE: TFX), a prominent player in the global medical technology landscape, has announced the U.S. Food and Drug Administration (FDA) 510(k) clearance for expanded...

Merger and Acquisition

Teleflex to Acquire BIOTRONIKs Vascular Intervention Business

Published Thu, Feb 27 2025 11:30 AM UTC

Teleflex s Strategic Acquisition: Advancing the Interventional Portfolio with BIOTRONIK’s Vascular Intervention BusinessTeleflex Incorporated (NYSE: TFX), a prominent player in the medical equipment and supplies sector, is poised to amplify its Interventional portfolio through its recent acquisition of BIOTRONIK s vascular intervention business. This strategic move is set...

Product Service News

Teleflex Enhances Patient Care New Innovations in Prostate Cancer Treatment and Vascular Access Solutions Unv...

Published Thu, Oct 17 2024 10:45 AM UTC

In the rapidly evolving medical technology landscape, Teleflex Incorporated has marked a significant milestone by showcasing its latest innovations aimed at enhancing patient care. Recently presented data at the ASTRO 2024 conference shed light on the safety and efficacy of the Barrigel Rectal Spacer, a pioneering solution transforming radiation therapy for prostate cancer p...




Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 3.33
Price to Sales (Expected) -
Price to Book 1.99
PEG (TTM) -

Financial Strength Current
Quick Ratio 0.42
Working Capital Ratio 2.55
Leverage Ratio (MRQ) 1.2
Total Debt to Equity 0.85
Interest Coverage (TTM) -
Debt Coverage (TTM) 0.06

Per Share Current
Earnings (TTM) -22.62 $
Revenues (TTM) 41.54 $
Cash Flow (TTM) 1.16 $
Cash 6.99 $
Book Value 69.69 $
Dividend (TTM) 1.36 $

Efficiency Current
Revenue per Employee (TTM) 118,599
Net Income per Employee (TTM) -65,084
Receivable Turnover Ratio (TTM) 4.05
Inventory Turnover Ratio (TTM) 1.4
Asset Turnover Ratio (TTM) 0.26

Profitability Ratios Current
Gross Margin (MRQ) 56.16 %
Operating Margin (MRQ) 3.69 %
Net Margin (MRQ) -1.49 %
Net Cash Flow Margin (MRQ) -15.5 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield 0.98 %
Pay out Ratio (TTM) -



Teleflex Incorporated's Segments
Vascular    43.26 % of total Revenue
Interventional    37.39 % of total Revenue
Surgical    19.51 % of total Revenue
segments    100.15 % of total Revenue
Americas    60.77 % of total Revenue
EMEA    26.79 % of total Revenue
Asia    12.59 % of total Revenue

  Teleflex Incorporated Outlook

On October 31 2024 the Teleflex Incorporated provided following guidance

nnTeleflex Incorporated Reports Financial Outcomes for the Third Quarter and Provides Insight into the Full Year 2024 Guidancenn

WAYNE, Pa., October 31, 2024 – Teleflex Incorporated (NYSE: TFX) has today released its financial results for the third quarter, which concluded on September 29, 2024. In conjunction with this announcement, the Company has also shared its outlook for the full year 2024, although specific details regarding the projected financial guidance remain absent from the current report.

While the third-quarter results have been detailed, further clarification regarding the anticipated financial performance for 2024 is required to fully understand the Company’s guidance. ...





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.